Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis
Multiple sclerosis (MS) is a debilitating neurodegenerative disease characterized by demyelination and neuronal loss. Traditional therapies often fail to halt disease progression or reverse neurological deficits. Ibogaine, a psychoactive alkaloid, has been proposed as a potential neuroregenerative a...
Saved in:
| Main Authors: | David Qixiang Chen, José Adalberto Inzunza Domínguez, Juan Manuel Valle Uzeta, Abhiram P. Pushparaj, Jonathan E. Dickinson |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-02-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1535782/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Editorial: Neuroplasticity in multiple sclerosis
by: Yavor Yalachkov, et al.
Published: (2025-02-01) -
“Stable” vs. “silent progressive multiple sclerosis”: a real-world retrospective clinical imaging Brazilian study
by: Gustavo Medeiros Andrade FIGUEIRA, et al.
Published: (2022-02-01) -
Exploring the Pathophysiology, Diagnosis, and Treatment Options of Multiple Sclerosis
by: Simone Lorenzut, et al.
Published: (2025-01-01) -
Further education in psychedelic-assisted therapy – experiences from Switzerland
by: H.D. Aicher, et al.
Published: (2025-03-01) -
Exploring the Role of Psychedelic Experiences on Wellbeing and Symptoms of Disordered Eating
by: Nadine Loh, et al.
Published: (2025-03-01)